September 2019 – Market Research Insights

Medical Waste Management Market Represents At USD 33.4 Billion By 2025 : Grand View Research Inc.

San Francisco, 30 September 2019: The Report Medical Waste Management Market Analysis By Services (Onsite: Collection, Recycling, Treatment; Offsite: Collection, Recycling, Treatment), By Treatment (Incineration, Autoclaving, Chemical), And Segment Forecasts, 2018 – 2025

The global medical waste management market is expected to reach USD 33.4 billion by 2025, according to a new report by Grand View Research, Inc. The development of innovative manufacturing techniques in pharmaceuticals, medical devices is growing with rapid pace. The rise in hospitals, multispecialty clinics and diagnostic centers that require large number of inventories for day to day functioning is also leading to generation of more waste. Thus, overall growth in healthcare industry coupled with rising patient population requiring prolong medical and surgical aid is fueling the market growth.

Rapid growth in initiatives by government to support and raise funds in effective waste management is anticipated to drive the market growth. These programs are conducted for creating awareness regarding the importance of systems for proper waste disposal. Additionally, taking steps to set standards and guidelines for the same is anticipated to propel the market growth.

The medical waste management involves high capital investment for managing hazardous by-products and disposal of infectious material. This disposal and recycling processes are associated with release of hazardous gases and compounds which may disturb the ecosystem and are likely to affect the industry growth.

Access Research Report of Medical Waste Management Market @ www.grandviewresearch.com/industry-analysis/medical-waste-management-market

Further key findings from the study suggest:

The growing prevalence of infectious and chronic diseases coupled with overall growth of healthcare industry is augmenting the market growth
Most of the waste disposal treatments are performed offsite, however, to save cost and holding time, onsite treatment sites are expected to grow over the forecast period
The incineration segment accounted for the largest revenue share in 2016 however, other sophisticated non-incineration processes that are ecofriendly are projected to replace traditional incinerators
In 2016, North America dominated the global space with the largest revenue share of over 32.0% owing to growing healthcare industry and development of innovative techniques for disposal of material
Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding effective disposal and recycling.
Major players competing in the industry include but are not limited to Remondis Medison GmbH; Republic Services, Inc.; Sharp Compliance, Inc.; Stericycle, Inc.; Suez Environment, Inc.; Veolia Environment S.A.; Waste Management, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the medical waste management market by services, treatment and region:

Medical Waste Management Services Outlook (Revenue, USD Million; 2014-2025)

Onsite
- Collection
- Treatment
- Recycling
- Others
Offsite
- Collecting, transportation, storage
- Treatment
- Recycling
- Others

Medical Waste Management Treatment Outlook (Revenue, USD Million; 2014-2025)

Incineration
Autoclaving
Chemical treatment
Others

Regional Outlook (Revenue, USD Million; 2014-2025)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Medical Waste Management Market @ www.grandviewresearch.com/press-release/global-medical-waste-management-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Drug Eluting Stent Market Poised To Augment The Industry At $ 9.2 Billion By 2024 : Grand View Research Inc.

San Francisco, 30 September 2019: The Report Drug Eluting Stent Market, By Polymer-based Coatings (Non-biodegradable Polymer-based, Biodegradable Polymer-based), Polymer-free Coatings (Micro Porous Surface, Microstructured Surface, Slotted Tubular Surface, Nanoporous Surface), By Application (Coronary Artery Disease, Peripheral Artery Disease), And Segment Forecasts To 2024

The global drug eluting stent market is anticipated to reach USD 9.2 billion by 2024, according to a new report by Grand View Research, Inc. The increasing geriatric population and the high prevalence of artery diseases are the major factors driving the market growth. Sedentary lifestyles, unhealthy dietary habits, and lack of exercise are some of the factors resulting in the increased prevalence of atherosclerosis. As a result, the demand for Drug Eluting Stents (DES) is escalating as atherosclerosis is widely treated using DES. In addition, a constant decline in the price coupled with the reimbursement coverage is spurring the adoption of DES in the treatment of arterial diseases.

Risks, such as thrombosis and disruption of regrowth of endothelial tissues associated with DES, are challenging the market growth. In addition, stringent regulatory approval guidelines are impeding the market growth by restricting the entry of advanced DES, such as bioabsorbable products, in the developed countries.

Presently, the DES market is highly fragmented with the presence of many players competing with each other. The key players in the market are implementing mergers and acquisitions strategies to strengthen their position in the market by the expansion of market share and customer base.

Access Research Report of Drug Eluting Stent Market @ www.grandviewresearch.com/industry-analysis/drug-eluting-stent-market

Further key findings from the study suggest:

The polymer-based coating stent segment was dominating the global market and is estimated to remain dominant throughout the forecast period. The increasing adoption of biodegradable stents is mainly driving the growth of the polymer-based coating stents segment.
The biodegradable polymer-based drug eluting stents are anticipated to have a high demand during the forecast period due to aminimally invasive technique and lesser risk of late stent thrombosis.
The demand for polymer-free drug eluting stents is going to increase considerably with new products entering the market, especially in emerging countries such as Brazil, Mexico, and South Africa.
China, India, Brazil, and South Africa are anticipated to register a significant growth in the near future owing to the rising patient awareness related to DES, presence of the largest pool of geriatric population prone to arterial diseases, and the surging prevalence of chronic diseases such as diabetes and cardiac disorders
Less stringent regulatory approval procedures in Asia Pacific are offering the easy entry of the new products into the market.
Some key players operating in the market include Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Lepu Medical Technology, Biotronik, Stentys, and Terumo Medical Corporation.
North America dominated the global market with a share of 40% in 2015. Technological advancements, such as the introduction of biodegradable stents primarily, led to the highest revenue generation in the region.
In addition, the reimbursement coverage, the presence of a large target patient population, and a well-defined regulatory framework are a few factors that are positively affecting the market.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the drug eluting stent market on the basis of product, application, and region:

Drug Eluting Stent Market, by Product, 2013 – 2024 (USD Million)

Polymer-based Coatings
Polymer-free Coatings

Drug Eluting Stent Market, by Application, 2013 – 2024 (USD Million)

Coronary Artery Disease
Peripheral Artery Disease

Drug Eluting Stent, by Region, 2013 – 2024 (USD Million)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Drug Eluting Stent Market @ www.grandviewresearch.com/press-release/global-drug-eluting-stent-market

About Grand View Research

For More Information: www.grandviewresearch.com

Protein Labeling Market Is Expected To Reach USD 2.60 Billion By 2024 : Grand View Research Inc.

San Francisco, 30 September 2019: The Report Protein Labeling Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Services), By Application (Immunological Techniques, Fluorescence Microscopy), By Labeling Method, And Segment Forecasts, 2018 – 2024

The global protein labeling market size is expected to reach USD 2.60 billion by 2024, according to a new report by Grand View Research, Inc., registering a CAGR of 9.3% during the forecast period. Development and commercial launch of high accuracy and rapid labeling products is expected to enhance market growth.

Post-translation Modification (PTM) such as proteolysis, lipidation, acetylation, methylation, nitrosylation, ubiquitination, glycosylation, and phosphorylation influence all aspects of pathogenesis as well as normal cell functioning. PTM studies are rapidly being adopted to investigate biological functions of various proteins and their role in disease prognosis.

Availability of a broad range of labels for covalent attachment of different molecules provides researchers the choice to select labels to suit specific applications. Fluorescent labeling does not require additional reagents for protein detection due to its ability to respond to light signals. This ability of fluorescence molecules has significantly contributed to its rapid adoption in in vivo protein labeling.

High R&D spending to reduce complexity in protein labeling and increased adoption of sophisticated bioengineering techniques in various sectors of biotechnology further contribute to market growth. Development of rapid diagnostic tests based on detection of the presence of specific protein proves to be of great significance for rapid and cost-effective diagnostics. Focus on development of advanced diagnostic tests based on protein detection is expected to fuel new product development.

Technological advancements in genetic sequencing methodologies has drastically reduced the cost of genome profiling. This is expected to drive demand for protein expression analysis, which is the next step in genetic analysis after sequencing. Declining sequencing cost has increased the number of proteomic and genomic profiling studies, which is projected to fuel demand for protein labeling over the forecast period.

Access Research Report of Protein Labeling Market @ www.grandviewresearch.com/industry-analysis/protein-labeling-market

Further key findings from the report suggest:

Rapid adoption of post-translational modification studies in proteomics is expected to fuel demand for reagents
SNAP-, CLIP-, MCP-, and ACP- tags are some of the fusion proteins used for covalent labeling. Ability to provide irreversible covalent labeling and labeling for membrane protein drives demand for probes/tags in labeling
Demand for kits for clinical diagnosis of various diseases based on protein detection fuels the kits product segment
North America dominated the market due to presence of key players and high investments in proteomics research. Canada is poised to witness lucrative growth owing to increasing number of research projects focused on improving healthcare solutions
Europe is a key regional market. The Seventh Framework Program of the European Union provided funds for P-CUBE – an infrastructure for Protein Production Platforms to provide access to most advanced techniques to researchers
Asia Pacific is expected to observe remarkable growth over the forecast period, especially in China and Japan
Major companies operating in the market include F. Hoffmann-La Roche AG; GE Healthcare Life Science; Promega Corporation; PerkinElmer Inc.; Merck Millipore; Thermo Fisher Scientific Inc.; Kirkegaard & Perry Laboratories (KPL); Eurogentec S.A.; New England Biolabs; and LI-COR Inc.
Key players are involved in acquisition of smaller players and are expanding their product portfolio, resulting in market consolidation.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global protein labeling market on the basis of product, application, labeling method, and region:

Protein Labeling Product Outlook (Revenue, USD Million, 2013 – 2024)

Reagents
- Protein
- Enzymes
- Probes/ tags
- Monoclonal antibodies
- Other reagents
Kits
Services

Protein Labeling Application Outlook (Revenue, USD Million, 2013 – 2024)

Cell based-assay
Fluorescence microscopy
Immunological techniques
Mass spectrometry
Protein micro assay

Protein Labeling Method Outlook (Revenue, USD Million, 2013 – 2024)

In vitro
- Enzymatic labeling
- Dye based labeling
- Co translational labeling
- Site specific labeling
- Nano particle labeling
In vivo
- Photo reactive labeling
- Radioactive labeling

Protein Labeling Regional Outlook (Revenue, USD Million, 2013 – 2024)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Access Press Release of Protein Labeling Market @ www.grandviewresearch.com/press-release/global-protein-labeling-market

About Grand View Research

For More Information: www.grandviewresearch.com

Medical Sensors Market Projected To Expand At USD 18.5 Billion By 2024 : Grand View Research Inc.

San Francisco, 30 September 2019: The Report Medical Sensors Market Analysis, By Product (Pressure Sensors, Temperature Sensors, Image Sensors, Accelerometers, Biosensors, Flow Sensors, SQUID Sensors), By Application Area (Surgical, Diagnostic, Therapeutic, Monitoring), By End-use (Hospitals, Physician Offices, Nursing Homes, Home Healthcare) And Segment Forecasts To 2024

The medical sensors market is expected to reach USD 18.5 billion by 2024, according to a new report by Grand View Research, Incite upsurge in the number of patients afflicted with chronic conditions, such as diabetes and hypertension, is fueling the usage of monitoring as well therapeutic devices, thus boosting the market demand.

The target population for this market is patients with chronic illnesses, as such conditions necessitate regular checkups and intermittent or continuous patient monitoring. The rise in population of chronically ill patients further increases the uptake of the medical sensors.

The geriatric population is highly prone to developing chronic disorders and they pose a higher risk of developing age-related deformities and complications. Moreover, the adoption of unhealthy food habits and sedentary lifestyles and the resultant surge in the incidence of obesity has led to the increasing prevalence of lifestyle disorders including diabetes. The presence of a large target population base combined with the prevalence of lifestyle-related risk factors is likely to accelerate the growth of the medical sensors market during the forecast period.

Technological advancements in terms of accuracy, portability, and affordability associated with the new generation medical sensors resulted in the increased usage of these devices; for instance, the introduction of easy-to-operate, home-based diagnostic kits that are cost effective.

Access Research Report of Medical Sensors Market @ www.grandviewresearch.com/industry-analysis/medical-sensors-market

The biosensors products segment held a lucrative share of over 40.0% in 2015. This is ascribable to the following attributes of the novel biosensors: durability, reliability, and accuracy. Moreover, their applications in the healthcare areas, such as the detection of drug abuse, glucose monitoring for diabetes, the detection of cholesterol, and others. All these elements governed the growth of this segment in 2015.
The surgical applications of the sensors dominated the market in 2015. Whereas, the monitoring applications segment is projected to be the fastest growing during the forecast period. Advancements, such as wearable technology are anticipated to boost the demand for the monitoring devices market.
The hospitals registered a remunerative growth in 2015; this can be attributed to the presence of a well-developed healthcare infrastructure, which yields faster and accurate diagnosis. Moreover, the availability of well-equipped infrastructure coupled with the presence of skilled personnel and technologically advanced equipments contribute towards the lucrative growth of this segment.
North America held a considerably large share of over 35.0% in 2015 owing to the presence of leading sensor manufacturers, a well-planned medical reimbursement network, and the increasing disposable income
On the contrary, Asia Pacific is anticipated to be the fastest growing region with a CAGR of over8.0% over the forecast period. The favorable economic developments and the advancing healthcare system with the aid of supportive government initiatives are anticipated to further assist the growth. Moreover, the increasing base of the aging population in this region also, additionally impels the demand. According to the report published by the Ministry of Statistics, in India, 8.6% of the total population is aged above 60; hence, presenting a profitable opportunity for the market players to invest in this region.
The leading players of the medical sensors market include Analog devices, Inc., Avago technologies Ltd., Danaher Corporation, GE Measurement &Control Solutions, Inc., Honeywell International, Inc., Stellar technologies, Inc., OmniVision Technologies, Inc., Sensation AG, TE Connectivity Ltd., Micro-Epsilon Messtechnik GmbH Co. & KG, and NXP Semiconductors N.V.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the medical sensors market on the basis of product, application area, end-use, and region.

Global Medical Sensors Market, by Product, Revenue, 2013 – 2024 (USD Million)

Pressure sensors
Temperature sensors
Image sensors
Accelerometers
Biosensors
- Cholesterol sensors
- Blood glucose sensors
- Pregnancy testing
- Drug discovery
- Infectious diseases
- Others
Flow sensors
SQUID sensors
Others

Global Medical Sensors Market, by Application, Revenue, 2013 – 2024 (USD Million)

Surgical
Diagnostic
Therapeutic
Monitoring
Others

Global Medical Sensors Market, by End-use, Revenue, 2013 – 2024 (USD Million)

Hospitals
Physician offices
Nursing home
Home healthcare
Others

Medical Sensors Market, by Region, Revenue, 2013 – 2024 (USD Million)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Medical Sensors Market @ www.grandviewresearch.com/press-release/global-medical-sensors-market

About Grand View Research

For More Information: www.grandviewresearch.com

Cardiac Resynchronization Therapy (CRT) Market Projected To Ascend At The Fastest CAGR Of 7.9% For The Forecast Period From 2018 To 2025: Grand View Research Inc.

San Francisco, 30 September 2019: The Report Cardiac Resynchronization Therapy (CRT) Market Size Report By Product (Cardiac Resynchronization Therapy Pacemakers, Cardiac Resynchronization Therapy Defibrillators), By Region, And Segment Forecasts, 2018 – 2025

The global cardiac resynchronization therapy (CRT) market is expected to reach USD 9.2 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiac disorders and rising incidences of heart failure are expected to boost the CRT market growth over the forecast period.

According to statistics published by the Sudden Cardiac Arrest Foundation in 2016, about 6.0 million people within the U.S. region suffer from cardiac disorders, of which 0.8 million are affected by atrioventricular block leading to cardiac failure. Such a huge number leads to an increased cost of about USD 20.0-56.0 billion annually. CRT devices are being predominantly used to prevent the surgical cost and readmission rate in hospitals, thereby propelling its growth.

In addition, the on-going research to develop smaller, wireless/leadless and long-lasting CRT devices is expected to be a vital impact rendering driver. For instance, in September 2016, EBR Systems Inc., announced that it had attained the FDA Investigational Device Exemption (IDE) consent for their Wireless Stimulation Endocardially (WiSE) technology in the U.S.

This technology is capable of stimulating the left ventricle internally leading to superior performance in comparison to devices with pacing systems placed near the collar bone. The study is expected to be started by mid-2017 with complete support by the FDA in terms of regulatory compliance, and financial aid.

Access Research Report of Cardiac Resynchronization Therapy (CRT) Market @ www.grandviewresearch.com/industry-analysis/cardiac-resynchronization-therapy-devices-market

Further Key Findings From the Study Suggest:

CRT-D products are expected to dominate over the forecast period. According to a paper published in the Journal of Cardiovascular Electrophysiology, more than half of the CRT product implants are done using CRT-D.
Asia Pacific and Latin American region are expected to witness lucrative growth and contribute over 30.0% of the revenue in 2025. This has been attributed to the rapid expansion of industry players within these regions in terms of manufacturing as well as distribution.
Competitive pricing and necessity for high operational optimization are expected to help companies strengthen their foothold in growing economies such as India, Mexico, and others.
Additionally, countries such as Japan are also observed to register high adoption rate for quadripolar lead-based CRT-D devices. This is expected further boost market growth.
Major market players of the industry are Medtronic Plc., BIOTRONIK, LivaNova Plc., St. Jude Medical, and Boston Scientific. However, a more assorted marketplace exists for vendors of leads (wireless and wired) that are used in the system.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global CRT market on the basis of product and region:

CRT Product Outlook (Revenue, USD Million, 2014 – 2025)

CRT-D
CRT-P

Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Access Press Release of Cardiac Resynchronization Therapy (CRT) Market @ www.grandviewresearch.com/press-release/global-cardiac-resynchronization-therapy-devices-market

About Grand View Research

For More Information: www.grandviewresearch.com

eHealth Market Is Developing At USD 308.0 Billion By 2022 : Grand View Research Inc.

San Francisco, 30 September 2019: The Report eHealth Market Analysis By Product (EHR, ePrescribing, Clinical Decision Support, Telemedicine, Consumer Health Information, mHealth, Health Management, Information System), By Services (Monitoring, Diagnostic, Healthcare Strengthening), By End-Use (Providers, Insurers, Government, Healthcare Consumers) And Segment Forecasts To 2022

Global eHealth market is expected to reach USD 308.0 billion by 2022, according to a new report by Grand View Research Inc. The transition of the healthcare industry into digital healthcare system for management and analysis of patient health is expected to be the most vital driver of the market.

Increasing prevalence of chronic diseases, and technological advancements in this field are few impact rendering factors. Rising use of mobile technologies and internet along with increasing adoption for home care by patients is expected to propel market growth over the forecast period.

Furthermore, expanding scope of IT companies pertaining to the development of real-time applications and software catering to the healthcare industry is expected to drive demand over the forecast period. Federal agencies such as the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR), in order to encourage and popularise eHealth, formulated various policies since 2007. One of these is the eHealth Action Plan, formulated in December 2012, which includes 16 proposed actions to boost eHealth use, focused on increasing research, innovation, interoperability and adoption.

The American Health Information Community (AHIC) was chartered in the U.S. to make recommendations leading to the likely development of eHealth to the Secretary of the U.S. Health Department. Based on these recommendations, efforts are being made to increase awareness levels for currently available mobile applications and wearable remote monitoring devices.

The benefits encouraging higher demand include round the clock care service, wider and faster access to patient information, reduction of administrative and medical errors, self monitoring and management by patients and centralization of entire healthcare industry chain.

Access Research Report of eHealth Market @ www.grandviewresearch.com/industry-analysis/e-health-market

Further key findings from the report suggest:

The diagnostics segment of eHealth services market is expected to witness the fastest growth of above 15.0% over the next seven years owing to, the increasing number of patients with at least one chronic condition and rising prevalence of infectious diseases. According to the CDC, more than 50% population of the U.S. accounting for about 117 million people suffer from at least one chronic condition requiring routine monitoring.
The mHealth market is expected to be the largest and the fastest growing accounting for a market share of over 24.0% by 2022. According to statistics published by the American Telemedicine Association (ATA), the number of mHealth patents has increased multi-fold from 2000 to 2015 and over 44 million m-Health applications were downloaded in 2015 within North America.
North America is expected to dominate the market throughout the forecast period with a revenue share of over 30% by 2022. Presence of technologically updated population base and various current initiatives by the American Health Information Community (AHIC) are expected to be the drivers of this growth.
Key players of the market include IBM, McKinsey & Co., Motion Computing Inc., Epocrates Inc., Telecare Corp., Proteus Digital Health and Apple. In June 2014, Apple announced the integration of HealthKit platform into the upcoming iPhone operating system (iOS 8) which will provide a complete health overview of a person such as weight, sleep patterns, heart rates measures, blood pressure and calorie intake.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global eHealth market on the basis of products, services and region:

eHealth Service Outlook (Revenue, USD Billion, 2012 – 2022)

Monitoring Services
- Vital Sign Monitoring
- Special Monitoring
- Adherence Monitoring
- Accessories
  - Sensors
  - Diagnosis Services
  - Healthcare System Strengthening
  - Others

eHealth Type Outlook (Revenue, USD Billion, 2012 – 2022)

Electronic Health Record (EHR)
E-Prescribing
Clinical Decision Support
Telemedicine
Consumer Health Informatics
Health Management
mHealth
Healthcare Information System

eHealth End-use Outlook (Revenue, USD Billion, 2012 – 2022)

Providers
Public and Private Insurers
Government
Healthcare Consumers

eHealth Regional Outlook (Revenue, USD Billion, 2012 – 2022)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of eHealth Market @ www.grandviewresearch.com/press-release/global-e-health-market

About Grand View Research

For More Information: www.grandviewresearch.com

Healthcare Electronic Data Interchange (EDI) Market Size Worth $ 5.9 Billion By 2025 : Grand View Research Inc.

San Francisco, 27 September 2019: The Report Healthcare Electronic Data Interchange (EDI) Market Analysis By Component (Services, Solutions), Delivery Mode (Web & Cloud-based EDI, EDI Value Added Network, Direct EDI, Mobile EDI), By End-use, And Segment Forecasts, 2018 – 2025

The global healthcare EDI market is anticipated to reach USD 5.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 9.4% over the forecast period, owing to increasing government support for healthcare IT coupled with surge in number of end-users and increasing adoption of EDI.

In 2010, the ObamaCare Act (the Affordable Care Act) was passed in the U.S., which mandated the use of enrolled/dis-enrolled transactions between the payers and providers in the U.S. Implementation of favorable policy such as Health Insurance Portability & Accountability Act (HIPAA) to provide data privacy and security provisions to protect medical information is anticipated to propel the market growth. Increasing government funding for the EDI-Special Project congressional grants is befitting hospitals and non-profit organization, thereby expected to foster the market growth.

A surge in number of end-users such as payers, providers, pharmaceutical & medical device industries, and others are anticipated to fuel the demand of the EDI services or solutions during the market period. The healthcare payers use EDI for the evaluation of insurance claims before their payment settlement, prevention & detection of fraudulent claims to provide rapid services through collaborating with providers in order to gain a competitive advantage.

Access Research Report of Healthcare Electronic Data Interchange (EDI) Market @ www.grandviewresearch.com/industry-analysis/healthcare-electronic-data-interchange-edi-market

Further Key Findings From the Study Suggest:

The services segment held lucrative market share in 2016 and is expected to grow at a significant rate over the forecast period, owing to growing demand from healthcare and insurance providers for healthcare claims filing, its verification, and accounts receivables
The mobile EDI segment is expected to be the fastest growing segment over the forecast period due to technological developments in the healthcare industry and rising adoption of mobile solutions from healthcare providers
North America is expected to dominate the healthcare EDI market over the forecast period due to rising demand for innovative IT solutions to streamline workflows coupled with increasing regulatory requirements regarding patient safety
Some of the key players in healthcare EDI market are GE Healthcare; McKesson Corporation; Cognizant; Allscripts Healthcare Solutions Inc.; Siemens Healthineers; Optum, Inc.; Schreiner Group; The SSI Group, LLC; ZirMed Inc.; and Experian Information Solutions, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global healthcare EDI market on the basis of product, end-use, and region:

Healthcare EDI Component Outlook (Revenue, USD Million, 2014 – 2025)

Services
Solutions

Healthcare EDI Delivery Mode Outlook (Revenue, USD Million, 2014 – 2025)

Web and Cloud-based EDI
EDI Value Added Network (VAN)
Direct (Point-to-Point) EDI
Mobile EDI

Healthcare EDI End-use Outlook (Revenue, USD Million, 2014 – 2025)

Healthcare Payers
Healthcare Providers
Pharmaceutical & Medical Device Industries
Others

Healthcare EDI Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Access Press Release of Healthcare Electronic Data Interchange (EDI) Market @ www.grandviewresearch.com/press-release/global-healthcare-electronic-data-interchange-edi-market

About Grand View Research

For More Information: www.grandviewresearch.com

Exosomes Market Expected To Fuel Industry Growth With A CAGR Of 18.8% For The Forecast Period From 2018 To 2030: Grand View Research Inc.

San Francisco, 27 September 2019: The Report Exosomes Market Size, Share and Trends Analysis Report By Workflow (Isolation, Downstream Analysis), By Biomolecule Type (Non-coding RNA, mRNA, Protein, Lipid), By Application, And Segment Forecasts, 2018 – 2030

The global exosomes market size is expected to reach USD 2.28 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 18.8% during the forecast period. Nanovesicles, which play a major role in intercellular communication, are anticipated to witness a significant rise in R&D, thus leading to revenue growth in the coming years.

Application of these vesicles as carriers of functional content such as circulating nucleic acids, lipids, and proteins can be attributed to market growth. In addition, exosomes play an important role in immunosurveillance and tumor pathogenesis. Increasing research programs focusing on determining the role of exosomes in hepatocellular carcinoma (HCC) is estimated to drive the market.

Rising number of articles pertaining to exosomal research is encouraging R&D activities in the field. Currently, there are more than 4400 articles published about exosomes, with approximately 25% of these published in 2016 alone. In addition to the exponential rise in article publication, number of companies engaged in the research is also increasing.

These companies are taking advantage of the natural propensity of exosomes for the transmission of macromolecule payloads between cells. Application of these molecules in research activities related to therapeutics and diagnostics is projected to result in exponential growth in the coming years.

Moreover, increase in funding for R&D in this field is poised to positively influence industrial growth. Rise in funding capacity by public and private institutions is indicative of the importance of exRNA molecules across the community engaged in translational research pertaining to diagnostics and therapeutic product development.

Access Research Report of Exosomes Market @ www.grandviewresearch.com/industry-analysis/exosomes-market

Further key findings from the report suggest:

By workflow, downstream analysis will account for a little over half the market revenue in 2030, due to rising advancements in methods and instruments
Ultracentrifugation represented the leading share in the isolation methods segment owing to higher adoption of technology as compared to other methods of isolation. Immunocapture on beads is anticipated to witness the fastest growth over the forecast period due to advancements in lab-on-a-chip techniques
In 2016, cancer was the leading application segment with a valuation of USD 1.15 million. Increasing penetration of companies in oncology-based research on biomarker identification is contributing to the growth of the segment
North America commanded the dominant share in terms of market revenue due to presence of a large number of academic and private organizations engaged in the launch of novel technologies
Major participants operating in this sector include Takara Bio Company; Illumina, Inc.; Thermo Fisher Scientific, Inc.; Fujifilm; and Qiagen. Strategies adopted by these participants include patent filing, inauguration of certified production facility, and launch of novel instruments.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global exosomes market on the basis of workflow, biomolecule type, application, and region:

Exosomes Workflow Outlook (Revenue, USD Million, 2014 – 2030)

Isolation Methods
- Ultracentrifugation
- Immunocapture on beads
- Precipitation
- Filtration
Downstream Analysis
- Cell Surface Marker Analysis using Flow Cytometry
- Protein analysis using Blotting & ELISA
- RNA analysis with NGS & PCR
- Proteomic analysis using Mass Spectrometry
- Others

Exosomes Biomolecule Type Outlook (Revenue, USD Million, 2014 – 2030)

Non-coding RNAs
mRNA
Proteins /peptides
DNA fragments
Lipids

Exosomes Application Outlook (Revenue, USD Million, 2014 – 2030)

Cancer
Neurodegenerative diseases
Cardiovascular diseases
Infectious diseases
Others

Exosomes Regional Outlook (Revenue, USD Million, 2014 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Access Press Release of Exosomes Market @ www.grandviewresearch.com/press-release/global-exosomes-market

About Grand View Research

For More Information: www.grandviewresearch.com

Disposable Lead Wires Market Size Is Anticipated To Reach USD 999.4 Million By 2025 : Grand View Research Inc.

San Francisco, 27 September 2019: The Report Disposable Lead Wires Market Size & Forecast By Material (TPE, TPU, Silicon, PVC), By Machine Type (3 Lead, 5 Lead, 12 Lead, 6 Lead), By End-Use (Hospitals, Clinics, Long Term Facilities), And Trend Analysis From 2018 – 2025

The global disposable lead wires market is expected to reach USD 999.4 million by 2025, according to a new study by Grand View Research, Inc. Rising incidence of hospital-acquired infections (HAIs) is the key driving factor for the market growth. The reusable lead wires are the major cause of the hospital-acquired bloodstream infections. Use of disposable lead wires eliminates the risk of cross-contamination. In addition, it reduces the cost associated with the HAIs. The aforementioned benefits are presumed to boost the usage rates over the forecast period.

Moreover, rising number of government initiatives to promote the incorporation of patient safety procedures in hospital settings is presumed to drive the overall market growth during the forecast period. Furthermore, an introduction of technologically advanced disposable LWs is anticipated to drive the market growth over the forecast period. For instance, advanced disposable ECG-LWs with patented push-button design have superior capabilities in reducing alarms that are created by a failure of leads and absence of telemetry. These above-mentioned factors are anticipated to fuel the market growth.

Access Research Report of Disposable Lead Wires Market @ www.grandviewresearch.com/industry-analysis/disposable-lead-wires-market

Further Key Findings From The Study Suggest:

Thermoplastic Elastomer (TPE) is expected to witness lucrative growth over the forecast period, owing to the rising adoption to reduce infection rates in healthcare facilities
The advantages of TPE over other materials like PVC and rubber latex such as providing better flexibility, ease of processing enables high performance in a variety of application
The demand of the 5-lead machine type is expected to increase in coming years owing to the surge in demand for cost effective equipment in critical care settings
Ambulatory care centers are presumed to witness an exponential growth throughout the forecast period. This can be attributed to the rising significance of disposable LWs in patient monitoring
North America accounted for the largest share of disposable lead wires market owing to the rising mortality rates pertaining to heart diseases
Asia Pacific anticipated to witness lucrative growth as a result of unmet patient needs, rising healthcare expenditure and establishment by major global players is expected to drive segment growth during the forecast period
The key players are involved in strategic alliances to sustain the competition, such as merger & acquisitions, strategic partnerships, and geographic expansion
For instance, in February 2016, the company announced acquisition of Bellco from private equity firm Charme Capital Partners in a probe to business expansion

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the disposable lead wires market on the basis of material, machine type, end-use, and region:

Disposable Lead Wires Material Outlook (Revenue, USD Million, 2014 – 2025)

TPE
TPU
Others

Disposable Lead Wires Machine Type Outlook (Revenue, USD Million, 2014 – 2025)

3 Lead
5 Lead
Others

Disposable Lead Wires End-Use Outlook (Revenue, USD Million, 2014 – 2025)

Hospitals
Clinics
Long Term Facilities
Ambulatory & Home Care Settings

Disposable Lead Wires Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Disposable Lead Wires Market @ www.grandviewresearch.com/press-release/global-disposable-lead-wires-market

About Grand View Research

For More Information: www.grandviewresearch.com

Cystic Fibrosis (CF) Therapeutics Market Size To Reach Value USD 13.9 Billion By 2025 : Grand View Research Inc.

San Francisco, 27 September 2019: The Report Cystic Fibrosis (CF) Therapeutics Market Analysis By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration, By Region, And Segment Forecasts, 2018 – 2025

The global cystic fibrosis therapeutics market is expected to reach USD 13.9 billion by 2025, according to a new report by Grand View Research, Inc. The rising prevalence of Cystic Fibrosis (CF) globally, research & development activities undertaken by key players, and favorable initiatives undertaken by nonprofit organizations are expected to boost the market over the forecast period.

The rising prevalence of CF indicates the rising demand for treatment alternatives, thereby uplifting the market. The key players operating in this market in collaboration with nonprofit organizations focus on the development of novel therapeutics for treatment. Some of the drugs that are under clinical studies are VX-445 + tezacaftor + ivacaftor, PTI-428, QR-010, AZD5634, and POL6014.

Favorable initiatives taken by regional and national nonprofit organizations is one of the key factors propelling growth. These initiatives ensure support to CF patients. These organizations aid in research & development activities of these therapeutics and help improve the quality of life of these patients. For instance, North American Cystic Fibrosis Conference (NACFC) was formed in 1986 to provide a collaborative and educational forum to CF professionals to share advances in R&D related to CF therapeutics.

Access Research Report of Cystic Fibrosis (CF) Therapeutics Market @ www.grandviewresearch.com/industry-analysis/cystic-fibrosis-cf-therapeutics-market

Further key findings from the report suggest:

The global CF therapeutics market size was estimated at USD 3,560.5 million in 2016 and is expected to grow at a CAGR of 16.7% from 2017 to 2025
The CFTR modulator segment emerged as the largest segment in 2016 and the same segment is anticipated to witness fastest growth over the next 8 years owing to the approval of CFTR modulator, Orkambi and the presence of various investigational compounds under the pipeline.
Oral route of administration emerged as the largest segment with revenue of USD 2,266.4 million due to the ease of administration and convenience
North America accounted for the largest market share owing to the presence of Caucasian descents in this region. Improved healthcare infrastructure, reimbursements, and initiatives undertaken by the nonprofit organizations is expected to propel the market over forecast period,
The key players include AbbVie Inc., F. Hoffmann-La Roche Ltd.; Gilead, Novartis AG, Vertex Pharmaceuticals Inc., AIT (Advanced Inhalation Therapies), Alaxia, Teva Pharmaceutical Industries Ltd, Merck & Co. Inc., Alcresta Therapeutics Inc., Allergan, and AstraZeneca

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the cystic fibrosis therapeutics market on the basis of drug class, route of administration and region:

Cystic Fibrosis Therapeutics Drug Class Outlook (Revenue, USD Million, 2014 – 2025)

Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators

Cystic Fibrosis Therapeutics Route of Administration Outlook (Revenue, USD Million, 2014 – 2025)

Oral drugs
Inhaled drugs

Cystic Fibrosis Therapeutics Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Access Press Release of Cystic Fibrosis (CF) Therapeutics Market @ www.grandviewresearch.com/press-release/global-cystic-fibrosis-cf-therapeutics-market

About Grand View Research

For More Information: www.grandviewresearch.com

	knowledgesourcing1 on Modular Instruments Market Exp…
	knowledgesourcing1 on Spirometer Market is Predicted…
	james cofer on Ostomy Care And Accessories Ma…
	violintec on Railway Wiring Harness Market…
	Russel David on HR Analytics Market Projected…

	knowledgesourcing1 on Modular Instruments Market Exp…
	knowledgesourcing1 on Spirometer Market is Predicted…
	james cofer on Ostomy Care And Accessories Ma…
	violintec on Railway Wiring Harness Market…
	Russel David on HR Analytics Market Projected…